Keyphrases
COVID-19
100%
Inhibitor-1
100%
Interleukin-1 Receptor
100%
Tissue Factor Pathway inhibitor-2 (TFPI-2)
100%
Patients with COVID-19
44%
Thrombosis
25%
Venous Thromboembolism
20%
Endotheliopathy
15%
COVID-19 Patients
15%
Critically Ill Patients
15%
D-dimer
15%
Coagulation
15%
Coronavirus Disease (COVID)
15%
Interleukin-1β
15%
Interleukin
15%
Treatment Dose
10%
Severe Disease
10%
Inflammation
10%
P-selectin Glycoprotein ligand-1 (PSGL-1)
10%
Immunothrombosis
10%
Von Willebrand Factor Antigen
10%
Platelet Activation
10%
Lung
10%
Interleukin-6
10%
Genome-wide Association Study
10%
Hospitalized COVID-19 Patients
10%
Anakinra
10%
Disease Stage
5%
Clinical Trials
5%
Tissue Plasminogen Activator (t-PA)
5%
Chemokines
5%
Plasma Tissue
5%
Anticoagulation
5%
Neutrophil Extracellular Traps
5%
Retrospective Analysis
5%
Thrombosis Risk
5%
Formation Factor
5%
MR Analysis
5%
Platelet-leukocyte Interaction
5%
Coagulation Pathway
5%
Hyperinflammation
5%
Meta-analysis
5%
Fibrinogen
5%
Second-line Treatment
5%
Large Pools
5%
Coagulation Factor Deficiency
5%
ADAMTS13
5%
Hypofibrinolysis
5%
Thromboprophylaxis
5%
High Mortality
5%
Biological Effects
5%
Hemostasis
5%
Heparin Infusion
5%
Interleukin-1 Receptor Type 1
5%
Very Large Datasets
5%
Disease Severity
5%
Tissue Factor
5%
Fold Increase
5%
Trial Reporting
5%
Age-related Changes
5%
Prothrombin Time
5%
P-selectin
5%
Thrombotic Markers
5%
Additive Value
5%
Excessive Inflammatory Response
5%
Taking Part
5%
Thrombus Formation
5%
Hospitalized Patients
5%
Glycoprotein
5%
Inflammatory Mediators
5%
Moderate to Severe
5%
Antagonism
5%
Platelet Count
5%
Blood Samples
5%
Trial Interventions
5%
Pathway Activation
5%
Horizontal Pleiotropy
5%
Mean Platelet Volume
5%
Critically Ill COVID-19 Patients
5%
Severe COVID-19
5%
Platelets
5%
Response to Treatment
5%
Genetic Variants
5%
Endothelial Tissue
5%
Therapeutic Blockade
5%
Arterial Thrombus
5%
Significant Benefit
5%
COVID-19 Severity
5%
Mendelian Randomization Analysis
5%
Sepsis Model
5%
Cellular Level
5%
Inverse Correlation
5%
4-fold
5%
Non-hospitalized
5%
Triage
5%
Circulating Levels
5%
Low Platelet Count
5%
Plasminogen Activator
5%
Medicine and Dentistry
COVID-19
100%
Tissue Factor Pathway Inhibitor
100%
Interleukin 1 Receptor
100%
Thrombosis
23%
Cytokine
20%
Venous Thromboembolism
15%
Biological Marker
15%
Interleukin 1
11%
Platelet
11%
Disease
11%
Dimer
11%
Von Willebrand Factor
7%
Anticoagulation
7%
Anakinra
7%
Genome Wide Association Study
7%
Lung
7%
P Selectin Glycoprotein Ligand 1
7%
Interleukin 6
7%
Thrombocyte Activation
7%
Clinical Trial
3%
Mediator
3%
Neutrophil
3%
Tissue Plasminogen Activator
3%
Artery Thrombosis
3%
Mendelian Randomization Analysis
3%
Leukocyte
3%
Von Willebrand Factor Cleaving Proteinase
3%
Blood Sampling
3%
Blood Clotting
3%
Biological Activity
3%
Blood Clotting Factor
3%
Disease Severity
3%
Interleukin 1 Receptor Type I
3%
Meta-Analysis
3%
Triage
3%
Sepsis
3%
Thromboplastin
3%
Severe Acute Respiratory Syndrome Coronavirus 2
3%
Serositis
3%
Lifespan
3%
Endothelium
3%
Pleiotropy
3%
Glycoprotein
3%
Low Platelet Count
3%
Protein Deficiency
3%
Heparin
3%
Blood Stasis
3%
Plasminogen Activator
3%
Fibrinogen
3%
Extracellular Trap
3%
Infusion
3%
Prothrombin Time
3%
Procoagulant
3%
Chemokine
3%
Mean Platelet Volume
3%
Pharmacology, Toxicology and Pharmaceutical Science
Interleukin 1 Receptor
100%
Tissue Factor Pathway Inhibitor
100%
Thrombosis
30%
Cytokine
25%
Biological Marker
20%
Venous Thromboembolism
20%
Inflammation
15%
Interleukin 1
15%
Disease
15%
Dimer
15%
Interleukin 6
10%
Anakinra
10%
Von Willebrand Factor
10%
P Selectin Glycoprotein Ligand 1
10%
Von Willebrand Factor Cleaving Proteinase
5%
Tissue Plasminogen Activator
5%
Sepsis
5%
Thromboplastin
5%
Interleukin 1 Receptor Type I
5%
Protein Deficiency
5%
Clinical Trial
5%
Fibrinogen
5%
Chemokine
5%
Blood Stasis
5%
Blood Clotting Factor
5%
Procoagulant
5%
Glycoprotein
5%
Heparin
5%
Plasminogen Activator
5%
SARS Coronavirus
5%
Artery Thrombosis
5%
Disease Severity
5%
Prothrombin
5%
Biochemistry, Genetics and Molecular Biology
Interleukin-1 Receptor
100%
Tissue Factor Pathway Inhibitor
100%
Cytokine
25%
Interleukin-1
15%
Interleukin
15%
Von Willebrand Factor
10%
Platelet
10%
Platelet Count
10%
Anticoagulation
10%
Genome-Wide Association Study
10%
Interleukin 6
10%
P-Selectin Glycoprotein Ligand-1
10%
Thrombocyte Activation
10%
Animal Model
10%
Genetic Divergence
5%
Mendelian Randomization
5%
Blood Coagulation Factor
5%
Lifespan
5%
Pleiotropy
5%
Leukocyte
5%
Blood Plasma
5%
ADAMTS13
5%
Mean Platelet Volume
5%
Thromboplastin
5%
SARS Coronavirus
5%
Tissue Plasminogen Activator
5%
Heparin
5%
Hemostasis
5%
Coagulation System
5%
Interleukin 1 Receptor, Type I
5%
Prothrombin Time
5%
Biological Activity
5%
Fibrinogen
5%
Mediator
5%
Plasminogen Activator
5%
Chemokine
5%
Glycoprotein
5%
Clinical Trial
5%
Blood Sampling
5%